Climate Change and Desertification - The following is a link to an extensive New York Times article regarding the expansion of the Tengger desert in China and the impact of this change on the affected population -
An understanding of science in this the 21st century is an essential ingredient for leading a productive and rewarding life.
Saturday, November 5, 2016
Saturday, October 29, 2016
Integration of Newly-Formed Neurons within the Adult Human Brain
The learning process that proceeds within the adult human
brain has long been an intense interest of study for neuroscientists especially
in regards to the events that unfold on a cellular and molecular level. It has been shown that physical activity as
well as the experience that comes with being in novel environments triggers the
production, development and eventual connectivity of newly-formed neurons
within the adult human brain.
Diego D. Alvarez and his colleagues (Laboratorio de
Plasticidad Neuronal, Fundación Instituto Leloir–Instituto de Investigaciones
Bioquímicas de Buenos Aires–Consejo Nacional de Investigaciones Científicas y
Técnicas (CONICET), Av. Patricias Argentinas 435, Buenos Aires C1405BWE,
Argentina) focused their studies on the mechanism through which the experience
of an enriched environment (EE) impacts the incorporation of newly-formed adult
neurons into the hippocampal network – an area of the human brain involved in retaining
declarative (explicit) memory.
Declarative memory refers to the memory of facts and events.
The cells of interest are referred to as granule cells (GCs)
(see image below). In the investigators’
study of newly-formed GCs using the mouse animal model, they found that
exposing the test animal subjects to EE accelerated the incorporation of these
neurons into the microcircuits of the dentate gyrus – the apparent site for the
establishment of new memories.
Granule Cells
In addition, further study demonstrated that in order for
this incorporation of new GCs to proceed, the process required the participation
of parvalbumin y-aminobutyric acid-releasing
interneurons (PV-INs). Inactivation of
PV-INs effectively prevented the effects of EE.
Neuronal stem cells (NSC) of the adult hippocampus are the precursors of
GCs of the dentate gyrus.
These results further our understanding of the complex cellular
and molecular mechanisms involved in incorporating new memories in the adult
human brain.
Friday, October 14, 2016
Natural Killer Cells in the Treatment of Cancer
It has been well established that the human immune system
has the inherent capability to recognize and eliminate aberrant tissue cells in
the body that have become transformed into cancerous cells capable of
metastasis. The natural process of
finding and eliminating these cells is referred to as cancer surveillance. It is this understanding that has led to the
development of clinical approaches taking advantage of this phenomenon. The techniques employed in this regard are
classified under the heading, cancer
immunotherapy.
There is a particular subset of circulating immuno-competent
white blood cells referred to as natural killer cells that play a significant
role in the body’s response to infectious pathogens as well as in cancer
surveillance (see image below). Dr.
Rizwan Rowee and is colleagues from the Department of Medicine, Oncology
Division Washington University School of Medicine in St. Louis investigated the
properties of natural killer cells in regard to their ability to identify and
destroy cancerous cells. They were
particularly interested in their “memory” capacity. It has long been known that subsets of immuno-competent
cells retain the capacity to recognize and attack particular targets from
previous encounters. This is an indispensable
feature of a normal immune system.
Natural Killer Cells Attacking a Target Cell
Following exhaustive study and analysis of these natural
killer cells with human leukemic cells in culture, the investigators discovered
that natural killer cells with memory-like capability actually demonstrated an
anti-leukemic effect against patients with acute myeloid leukemia (AML). In some cases, this treatment led to clinical
remissions. The investigators reported
that, “Clinical responses were observed in five of nine evaluable patients,
including four complete remissions. Thus, harnessing cytokine-induced
memory-like NK cell responses represents a promising translational
immunotherapy approach for patients with AML.”
These are very important findings especially in regard to
the treatment of patients with AML; since, this disease is a particularly aggressive
form of leukemia.
Monday, October 10, 2016
Dr. Arnoldo Gabaldón
Malaria is one of the world’s deadliest
diseases. It is especially prevalent in
the tropics. The life cycle of the causative
microbial parasite – members of the plasmodium genus i.e. Plasmodium vivax is
complex involving the Anopheles mosquito as a vector (see images below). The nature of the infection is such that it
has eluded the development of an effective vaccine for many years.
Human red cells infected by Plasmodium vivax
In light of this, it is quite surprising
that Dr. Arnoldo Gabaldón, born in 1909, in Venezuela made a significant
contribution to the understanding of this disease and its implications in
regard to public health.
Gabaldón earned a doctorate in medical
sciences at the Universidad Central de Venezuela. He continued his education
internationally working in Hamburg and the United States at the Rockefeller Foundation and ultimately received
a doctorate from Johns Hopkins University in hygiene sciences with a specialty
in protozoology. With this kind of medical background and expertise in
infectious disease, he was asked to head the newly created Special Directorate
of Malariology in his home country of Venezuela in 1936. He held this post until 1950.
He successfully applied his understanding
of the methodologies required to combat infectious disease to the rate and
severity of malarial infection that gripped his country in the 1930s. This included the emphasis on public hygiene
and sanitation and the judicious application of anti-malarial drugs. His
approach was so successful that mortality resulting from malarial infection was
decreased significantly by 1944 and, more importantly, its control was seen as within
reach.
This initial success was followed by an
attempt to significantly reduce the Anopheles mosquito population. For this purpose, the insecticide dichlorodiphenyltrichloroethane
(DDT) was used. The historic data has revealed
that “by 1950 the death rate from malaria in the country had been reduced to 9
per 100,000 inhabitants and was eradicated in an area of 132 000 km2. In 1955,
10 years after the program started the rate was lowered to 1 per 100 000
population and the eradicated area had increased to 305,414 km2.” On balance,
it should be kept in mind that the discovery of the ecological burden posed by
the use of DDT on the natural environment has effectively banned its application
for many years.
Gabaldón is also credited with discovering
a new species of malarial parasites and had focused a great deal of his efforts
on further study of the Anopheles mosquito.
He was later appointed Minister of Health and Welfare between 1959 and
1964 in recognition of his premier understanding regarding issued of public
health. He died in September of 1990.
Arnoldo Gabaldón made a significant
contribution to the principles and practices of public health around the area
of infectious disease. The example of
his leadership has been emulated throughout the world and possibly has saved
countless lives.
Tuesday, September 20, 2016
The C9ORF72 Protein as a Suppressor of Autoimmunity
There are many chronic illnesses
that are referred to as autoimmune diseases such as multiple sclerosis,
amyotrophic lateral sclerosis (ALS) and pemphigus vulgaris for example; the etiology
of these diseases originates from the patient’s immune system attacking normal
tissue.
ALS is a disease that presents as
a progressive degeneration of the normal function of motor neurons resulting in
paralysis and death. It has been shown
that mutations in the C9ORF72 gene are commonly found in ALS and frontotemporal
dementia. This gene is located on the
short arm of chromosome 9 in humans.
This gene contains the information for the production of the C9orf72 protein. Furthermore, in animal model studies using
the mouse, it has been found that mutations in this gene result in
Autoimmune-like symptoms.
Transplantation of normal murine bone marrow positively impacted diseased
mice with this mutation and bone marrow transplantation of diseased mice into
normal animals alternatively resulted in symptoms of autoimmunity. These latter results led investigators to
suspect that the C9orf72 gene is normally
active in hematopoietic cells – cells residing in the bone marrow that produce
circulating blood cells - in suppressing autoimmunity.
Recent findings have clearly
established that mice that harbor mutations in the C9orf72 gene that result in the loss of function of the C9orf72 protein gene product develop
the following symptoms –
- splenomegaly – enlarged spleen
- neutrophilia – increased population of neutrophils in the circulation
- thrombocytopenia – decreased numbers of platelets
- increased expression of inflammatory cytokines
- severe autoimmunity.
These
diseased animal suffer a high mortality rate.
These data represent strong
evidence that the C9ORF72 gene plays a very important role in the suppression
of autoimmunity and may prove to be of future therapeutic value.
Tuesday, September 6, 2016
What Will be Our Legacy?
The essential questions I would
like to pose are the following-
- Are we prepared to leave as our legacy not only to future generations of humans, but also the future of our fellow creatures a world whose living populations will be severely decimated by the onslaught of climate change brought on by human activity?
- Are we prepared to jeopardize the quality of life and security of future generations of humanity on planet Earth so that we can maintain our privileged and comfortable lifestyles based upon a patent disregard for the environmental degradation that we necessarily impose upon our planet?
These questions are no longer
simply philosophical in nature. The
current data is clear that we are in the midst of a major change in the global
environment caused primarily by human activity.
The following statement was made within the Smithsonian Museums website –
Smithsonian.com – “According to the International Union of Geological Sciences
(IUGS), the professional organization in charge of defining Earth’s time scale,
we are officially in the Holocene (“entirely recent”) epoch, which began 11,700
years ago after the last major ice age.
“But that label is outdated, some
experts say. They argue for “Anthropocene”—from anthropo, for “man,” and cene,
for “new”—because human-kind has caused mass extinctions of plant and animal
species, polluted the oceans and altered the atmosphere, among other lasting
impacts.”
Humanity’s response, within the
21st century, to this real crisis will determine the future that
awaits the living world. Of course, the
earth has been through at least five major mass extinctions in its long
geological history and will certainly survive another. The kind of adjustments involved, however,
require long stretches of time involving many thousands if not millions of
years. We do not have the luxury of waiting. The future of the natural environment depends
upon what we do, or what we fail to do now.
Wednesday, August 31, 2016
The Role of the Enzyme Acid Ceramidase in the Etiology of Cancer
Ceramide belongs to a class of bio-active organic compounds
referred to as sphingolipids.
This class of compounds has been
shown to play important roles in many cellular processes including cell growth
and proliferation, growth arrest and most importantly, apoptosis – programmed cell
death. Furthermore, research studies
have strongly implicated sphingolipid signaling dysfunction in tumor
progression – metastasis. In addition,
sphingolipids seem to play a role in the effect of chemotherapy and radiation
upon cancer progression in patients with metastatic disease.
The current data strongly suggests that the enzyme acid ceramidase
(AC) is implicated in both tumor growth and resistance to various therapeutic
modalities as suggested above. AC is an
enzyme that catalyzes the breakdown of ceramide to sphingosine and fatty acid
(see diagram below).
AC over expression
has been found in association with certain metastatic cancers including prostate
cancer. A decrease in the intracellular levels
of ceramide has been shown to result in a decrease in apoptosis that would
ordinarily lead to cell death for proliferating tumor cells.
As a consequence of these data, Daniele Piomelli, the Louise
Turner Arnold Chair in Neurosciences at UCI, and colleagues at the Italian
Institute of Technology, have also established an association with over
expression of AC and metastatic disease in melanoma patients. This group has proceeded to successfully develop
drugs that effectively inhibit AC in an attempt to restore an appropriate level
of apoptosis and slow down tumor progression.
Subscribe to:
Posts (Atom)







